Hint mode is switched on Switch off
For swift navigation between sections

Idorsia
LEI 506700XOVZUB107S5720

Organization name
Idorsia Ltd
Country name
Switzerland
Country of registration
Switzerland
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
743 mln USD

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds
  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

Idorsia is an independent biopharmaceutical company based on science and innovation. The company is specialized in the discovery and development of small molecules, to transform the horizon of therapeutic options. Idorsia was incorporated in March 2017 and listed on the SIX Swiss Exchange.

Awards

Documentation

Stocks

Latest issues

Public debt by currencies

Codes

  • LEI
    506700XOVZUB107S5720
  • NACE
    *** ***
  • NAICS
    *** ***
  • UID
    CHE340129854
Registration is required to get access.